Skip to main content

Advertisement

Log in

Streptococcus sanguinis and the sera of patients with Behçet’s disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

The glycolytic enzyme α-enolase is a plasminogen-binding protein that is generally found in the cytosolic compartment. However, α-enolase can also be expressed on cell surfaces following an inflammatory stimulus via an unknown mechanism. We investigated the effects of Streptococcus sanguinis (S. sanguinis) and the sera of patients with Behçet’s disease (BD) on the expression and distribution of α-enolase in human dermal microvascular endothelial cells (HDMECs). HDMECs were stimulated with cultured S. sanguinis and the sera of active BD patients. HDMECs incubated for 6, 12 or 24 h were harvested, and the membrane and cytoplasmic fractions of proteins were extracted. The expression and distribution of α-enolase were analyzed using subcellular fractionation and immunoblotting. Subcellular localization of α-enolase was also assessed by immunocytochemistry. S. sanguinis stimulated the expression of α-enolase in the membranous compartment of HDMECs in a dose-dependent manner. This pattern was also observed in HDMECs incubated with BD patients’ sera. Although incubation of HDMECs with sera from healthy controls increased membrane expression of α-enolase, incubation with BD sera resulted in earlier and higher expression of this glycoprotein in the cellular membrane of HDMECs. Immunocytochemistry revealed strong immunostaining of α-enolase in the cytoplasm and cytoplasmic membrane of HDMECs incubated with S. sanguinis or BD patients’ sera. In conclusions, these results indicate that S. sanguinis infection and the sera of BD patients with active disease are inflammatory stimuli that can induce membranous α-enolase expression in endothelial cells. Membrane-expressed α-enolase could potentially react with anti-α-enolase antibodies in BD patients’ sera, resulting in increased inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Angiolella L, Facchin M, Stringaro A, Maras B, Simonetti N, Cassone A (1996) Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J Infect Dis 173:684–690

    Article  PubMed  CAS  Google Scholar 

  2. Brandenburg LO, Varoga D, Nicolaeva N et al (2008) Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptides in meningitis. J Neuropathol Exp Neurol 67:1041–1054

    Article  PubMed  CAS  Google Scholar 

  3. Capello M, Ferri-Borgogno S, Cappello P, Novelli F (2011) α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J 278:1064–1074

    Article  PubMed  CAS  Google Scholar 

  4. Cappello P, Tomaino B, Chiarle R et al (2009) An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 125:639–648

    Article  PubMed  CAS  Google Scholar 

  5. Cho SB, Lee JH, Ahn KJ, Cho S, Park YB, Lee SK, Bang D, Lee KH (2010) Identification of streptococcal proteins reacting with sera from Behçet’s disease and rheumatic disorders. Clin Exp Rheumatol 28:S31–S38

    PubMed  Google Scholar 

  6. Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195–205

    Article  PubMed  CAS  Google Scholar 

  7. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 473:47–52

    Article  PubMed  CAS  Google Scholar 

  8. Fontan PA, Pancholi V, Nociari MM, Fischetti VA (2000) Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J Infect Dis 182:1712–1721

    Article  PubMed  CAS  Google Scholar 

  9. Ghosh AK, Steele R, Ray RB (1999) Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol 19:2880–2886

    PubMed  CAS  Google Scholar 

  10. He P, Naka T, Serada S et al (2007) Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98:1234–1240

    Article  PubMed  CAS  Google Scholar 

  11. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    Google Scholar 

  12. Kalayciyan A, Zouboulis C (2007) An update on Behçet’s disease. J Eur Acad Dermatol Venereol 21:1–10

    Article  PubMed  CAS  Google Scholar 

  13. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K (2008) The role of streptococcal hypersensitivity in the pathogenesis of Behçet’s disease. Eur J Dermatol 18:489–498

    PubMed  CAS  Google Scholar 

  14. Kolberg J, Aase A, Bergmann S, Herstad TK, Rødal G, Frank R, Rohde M, Hammerschmidt S (2006) Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. Microbiology 152:1307–1317

    Article  PubMed  CAS  Google Scholar 

  15. Lee JH, Cho SB, Bang D, Oh SH, Ahn KJ, Kim J, Park YB, Lee SK, Lee KH (2009) Human anti-alpha-enolase antibody in sera from patients with Behçet’s disease and rheumatologic disorders. Clin Exp Rheumatol 27:S63–S66

    PubMed  CAS  Google Scholar 

  16. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet’s disease. Arthritis Rheum 48:2025–2035

    Article  PubMed  CAS  Google Scholar 

  17. López-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fábregas P, Jardí M, Merton E, Miles LA, Félez J (2003) Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol 72:234–242

    Article  PubMed  Google Scholar 

  18. Merkulova T, Lucas M, Jabet C (1997) Biochemical characterization of the muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem J 323:791–800

    PubMed  CAS  Google Scholar 

  19. Moscato S, Pratesi F, Sabbatini A, Chimenti D, Scavuzzo M, Passatino R, Bombardieri S, Giallongo A, Migliorini P (2000) Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol 30:3575–3584

    Article  PubMed  CAS  Google Scholar 

  20. Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Büschenfelde KH, Mayet WJ (1998) Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 112:507–515

    Article  PubMed  CAS  Google Scholar 

  21. Pancholi V (2001) Multifactorial α-enolase: its role in diseases. Cell Mol Life Sci 58:902–920

    Article  PubMed  CAS  Google Scholar 

  22. Pancholi V, Chhatwal GS (2003) Housekeeping enzymes as virulence factors for pathogens. Int J Med Microbiol 293:391–401

    Article  PubMed  CAS  Google Scholar 

  23. Pancholi V, Fischetti VA (1998) Alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273:14503–14515

    Article  PubMed  CAS  Google Scholar 

  24. Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P (2000) Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol 27:109–115

    PubMed  CAS  Google Scholar 

  25. Ray R, Miller DM (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11:2154–2161

    PubMed  CAS  Google Scholar 

  26. Sugahara T, Nakajima H, Shirahata S, Murakami H (1992) Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells. Cytotechnology 10:137–146

    Article  PubMed  CAS  Google Scholar 

  27. Sabbatini A, Dolcher MP, Marchini B, Chimenti D, Moscato S, Pratesi F, Bombardieri S, Migliorini P (1997) Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 15:655–658

    PubMed  CAS  Google Scholar 

  28. Seweryn E, Pietkiewicz J, Bednarz-Misa IS, Ceremuga I, Saczko J, Kulbacka J, Gamian A (2009) Localization of enolase in the subfractions of a breast cancer cell line. Z Naturforsch C 64:754–758

    PubMed  CAS  Google Scholar 

  29. Yokota K, Hayashi S, Araki Y, Isogai E, Kotake S, Yoshikawa K, Fujii N, Hirai Y, Oguma K (1995) Characterization of Streptococcus sanguis isolated from patients with Behçet’s disease. Microbiol Immunol 39:729–732

    PubMed  CAS  Google Scholar 

  30. Yokota K, Oguma K (1997) IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet’s disease. Microbiol Immunol 41:925–931

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Suhyun Cho, Zhenlong Zheng, and Sung Bin Cho received financial support from a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. 2010-0022927).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dongsik Bang.

Additional information

S. Cho and Z. Zheng contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, S., Zheng, Z., Cho, S.B. et al. Streptococcus sanguinis and the sera of patients with Behçet’s disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells. Arch Dermatol Res 305, 223–232 (2013). https://doi.org/10.1007/s00403-012-1298-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1298-1

Keywords

Navigation